Royalty Rates & Licensing Agreement
Licensee: CEREBAIN BIOTECH CORP.
Licensor: DR. SURINDER SINGH SAINI, MD
Upfront Fee: $50,000.00
Agreement Date: 6/10/2010
Date Entered: 5/1/2012
Technology: Mammalian omentum and methods of using the same for treating symptoms and/or conditions related to dementia are provided. In addition, a composition comprising the omentum tissue and/or the extract thereof is described in some embodiments. In some other embodiments, methods of formulating and administering the composition are also provided. In addition, a cultured cell system to culture cells and/or tissues of the omentum is described. Some aspects of embodiments provide methods of identifying one or more biological agent from the omentum tissue. In another aspect of the embodiments, methods of testing the effect of stimulation omentum in treating dementia conditions are described. Patent US 20090191127 A1
Royalty Rates: 6% Net Sales
Agreement: License
Exclusive License: Yes, patent involved
Licensee SIC Code: NA
Licensor SI Code: NA
Notes: Within ninety (90) days from the effective date, Cerebain will pay Licensor US$ 50,000
Source:
SEC Form 8-K
Copyright ©2024
